Analyst Coverage
ANALYST COVERAGE
Below is a list of sell-side analysts actively covering Alnylam
Firm | Analyst | Contact Info |
---|---|---|
Bank of America Securities | Tazeen Ahmad | tazeen.ahmad@bofa.com |
Barclays | Gena Wang | gena.wang@barclays.com |
Bernstein | William Pickering | william.pickering@bernstein.com |
BMO | Kostas Biliouris | kostas.biliouris@bmo.com |
Canaccord Genuity | Whitney Ijem | wijem@cgf.com |
Cantor Fitzgerald | Olivia Breyer | olivia.brayer@cantor.com |
Chardan | Keay Nakae | knakae@chardan.com |
Citi | David Lebowitz | david.lebowitz@investmentresearch.citi.com |
Cowen | Ritu Baral | ritu.baral@cowen.com |
Evercore ISI | Liisa Bayko | liisa.bayko@evercoreisi.com |
Goldman Sachs | Salveen Richter | salveen.richter@gs.com |
Guggenheim | Debjit Chattopadhyay | debjit.chattopadhyay@guggenheimpartners.com |
H.C. Wainwright | Patrick Trucchio | ptrucchio@hcwresearch.com |
Jefferies | Maury Raycroft | mraycroft@jefferies.com |
J.P. Morgan | Jessica Fye | jessica.m.fye@jpmorgan.com |
Morgan Stanley | Michael Ulz | mike.ulz@morganstanley.com |
Morningstar | Rachel Elfman | rachel.elfman@morningstar.com |
Needham | Joseph Stringer | jstringer@needhamco.com |
Oppenheimer | Leland Gershell | leland.gershell@opco.com |
Piper Sandler | Ted Tenthoff | edward.tenthoff@psc.com |
Raymond James | Gary Nachman | gary.nachman@raymondjames.com |
RBC | Luca Issi | luca.issi@rbccm.com |
Stifel | Paul Matteis | matteisp@stifel.com |
Leerink | Mani Foroohar | mani.foroohar@leerink.com |
UBS | Eliana Merle | eliana.merle@ubs.com |
Wells Fargo | Tiago Fauth | tiago.fauth@wellsfargo.com |
William Blair | Myles Minter | mminter@williamblair.com |
Wolfe Research | Andy Chen | achen@wolferesearch.com |
Alnylam Pharmaceuticals, Inc., is followed by the analysts listed above. Please note that any opinions, estimates, or forecasts regarding Alnylam Pharmaceuticals, Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of Alnylam Pharmaceuticals, Inc., or its management. Alnylam Pharmaceuticals, Inc., does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.
Related Information
Our Pipeline › Events & Presentations › Press Releases › Capella › Our Products ›
Contact Us
Looking for specific information that isn't listed above?
Contact Us:investors@alnylam.com